Nephrada · IGAN · United Kingdom · Community nephrologist · captured by Dr. Anna Becker on 17 Apr 2026 · reviewed by Dr. Marcus Lindqvist on 23 Apr 2026
Verbatim as captured; never edited
Community nephrologist at Royal Marsden raised patient-reported outcomes during a scientific exchange. They indicated this influences their current prescribing approach.
Human-approved by Dr. Marcus Lindqvist on 23 Apr 2026
Patient-reported outcomes: practice variation observed reported by community nephrologist (GB).
helixor-private-llm-2026.05 · generated 17 Apr 2026, 10:00 UTC
AI summary
Patient-reported outcomes raised by community nephrologist; suggest routing to Medical Affairs.
Source spans used by the model
Community nephrologist at Royal Marsden raised patient-reported outcomes during a scientific exchange. They indicated this influences their current prescribing approach.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Education need | Education need |
| Function | Medical Affairs | Medical Affairs |
| Priority | Low | Low |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 1 | 20% | 4.0 |
| Strategic alignment | 2 | 20% | 8.0 |
| Scientific importance | 2 | 15% | 6.0 |
| Urgency | 2 | 15% | 6.0 |
| Novelty | 2 | 10% | 4.0 |
| Actionability | 1 | 10% | 2.0 |
| Confidence | 2 | 5% | 2.0 |
| Breadth of occurrence | 3 | 5% | 3.0 |
| Total | Low 35 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
16 Apr 2026 · Dr. Daniel Weber, Royal Marsden · MSL Dr. Anna Becker
Insight
Reviewed 23 Apr 2026 by Dr. Marcus Lindqvist
Action
Medical-information improvement · Fatima Al-Sayed · At risk
Decision
Outcome
Closure
Standard response created and approved.